Looks like Actinogen has some competition from overseas Biogen... not sure of the details but probably worth a read for anyone invested:
https://www.statnews.com/2019/10/22/biogen-to-submit-aducanumab/?linkId=76188262
https://time.com/5709023/biogen-alzheimers-drug/
Looks like Actinogen has some competition from overseas...
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $69.80M | |||
| Open | High | Low | Value | Volume |
| 3.1¢ | 3.1¢ | 3.0¢ | $14.46K | 475.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 510935 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 1142915 | 4 |
View Market Depth
| Last trade - 12.17pm 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
3.1¢ |
Change
0.000 ( 5.17 %) |
||||
| Open | High | Low | Volume | ||
| 3.0¢ | 3.1¢ | 3.0¢ | 818834 | ||
| Last updated 12.42pm 29/04/2024 ? | |||||
| ACW (ASX) Chart |